Satoh Shin-ichi, Yamaguchi Tamami, Hitomi Asako, Sato Norihiro, Shiraiwa Kazumi, Ikegaki Ichiro, Asano Toshio, Shimokawa Hiroaki
Institute of Life Science Research, Asahi Kasei Corporation, 632-1, Mifuku, Ohito-Cho, Tagata-Gun, Shizuoka 410-2321, Japan.
Eur J Pharmacol. 2002 Nov 29;455(2-3):169-74. doi: 10.1016/s0014-2999(02)02619-5.
This study was designed to investigate possible effects of the Rho-kinase inhibitor, fasudil, on the progression of renal failure in rats with unilateral ureteral obstruction. The renal failure markers monitored were the extent of renal interstitial fibrosis and that of macrophage infiltration. In kidneys with unilateral ureteral obstruction, interstitial fibrosis was observed, using Sirius-Red staining, on day 16 after unilateral ureteral obstruction. Macrophage infiltration was observed by immunohistochemistry, using the antibody, ED1. Interstitial fibrosis and macrophage infiltration were significantly attenuated in fasudil-treated animals. The migration of monocytes in vitro elicited by N-formyl-methionyl-leucyl-phenylalanine was potently inhibited by fasudil and its active metabolite, hydroxyfasudil. These results suggest that inhibition of Rho-kinase produces a reduction of macrophage infiltration and represents a new therapeutic strategy for renal fibrosis, a major factor in the progression to end-stage renal failure.
本研究旨在探讨Rho激酶抑制剂法舒地尔对单侧输尿管梗阻大鼠肾衰竭进展的可能影响。所监测的肾衰竭标志物为肾间质纤维化程度和巨噬细胞浸润程度。在单侧输尿管梗阻的肾脏中,通过天狼星红染色在单侧输尿管梗阻后第16天观察到间质纤维化。使用抗体ED1通过免疫组织化学观察巨噬细胞浸润。在法舒地尔治疗的动物中,间质纤维化和巨噬细胞浸润明显减轻。法舒地尔及其活性代谢产物羟基法舒地尔可有效抑制N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸诱导的体外单核细胞迁移。这些结果表明,抑制Rho激酶可减少巨噬细胞浸润,并代表了一种针对肾纤维化的新治疗策略,肾纤维化是终末期肾衰竭进展的主要因素。